-
1
-
-
0029826977
-
B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice
-
COI: 1:CAS:528:DyaK28XmvFait78%3D, PID: 8920894
-
Serreze DV, Chapman HD, Varnum DS, Hanson MS, Reifsnyder PC, Richard SD, et al. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice. J Exp Med. 1996;184(5):2049–53.
-
(1996)
J Exp Med
, vol.184
, Issue.5
, pp. 2049-2053
-
-
Serreze, D.V.1
Chapman, H.D.2
Varnum, D.S.3
Hanson, M.S.4
Reifsnyder, P.C.5
Richard, S.D.6
-
2
-
-
36849027817
-
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice
-
COI: 1:CAS:528:DC%2BD2sXhsValsL%2FP, PID: 18060033
-
Hu CY, Rodriguez-Pinto D, Du W, Ahuja A, Henegariu O, Wong FS, et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest. 2007;117(12):3857–67.
-
(2007)
J Clin Invest
, vol.117
, Issue.12
, pp. 3857-3867
-
-
Hu, C.Y.1
Rodriguez-Pinto, D.2
Du, W.3
Ahuja, A.4
Henegariu, O.5
Wong, F.S.6
-
3
-
-
43049171493
-
B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions
-
COI: 1:CAS:528:DC%2BD1cXit1OlurY%3D, PID: 18292508
-
Xiu Y, Wong CP, Bouaziz JD, Hamaguchi Y, Wang Y, Pop SM, et al. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J Immunol. 2008;180(5):2863–75.
-
(2008)
J Immunol
, vol.180
, Issue.5
, pp. 2863-2875
-
-
Xiu, Y.1
Wong, C.P.2
Bouaziz, J.D.3
Hamaguchi, Y.4
Wang, Y.5
Pop, S.M.6
-
4
-
-
58149359257
-
Targeting CD22 reprograms B-cells and reverses autoimmune diabetes
-
COI: 1:CAS:528:DC%2BD1MXhsleisrk%3D, PID: 18689692
-
Fiorina P, Vergani A, Dada S, Jurewicz M, Wong M, Law K, et al. Targeting CD22 reprograms B-cells and reverses autoimmune diabetes. Diabetes. 2008;57(11):3013–24. doi:10.2337/db08-0420.
-
(2008)
Diabetes
, vol.57
, Issue.11
, pp. 3013-3024
-
-
Fiorina, P.1
Vergani, A.2
Dada, S.3
Jurewicz, M.4
Wong, M.5
Law, K.6
-
5
-
-
67650272801
-
+) T-cells control autoimmunity in the absence of B-cells
-
COI: 1:CAS:528:DC%2BD1MXos1Cqurg%3D, PID: 19336675
-
+) T-cells control autoimmunity in the absence of B-cells. Diabetes. 2009;58(7):1568–77. doi:10.2337/db08-1504.
-
(2009)
Diabetes
, vol.58
, Issue.7
, pp. 1568-1577
-
-
Marino, E.1
Villanueva, J.2
Walters, S.3
Liuwantara, D.4
Mackay, F.5
Grey, S.T.6
-
6
-
-
71849093408
-
In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice
-
COI: 1:CAS:528:DC%2BD1cXhtl2gsLrP, PID: 19018006
-
Zekavat G, Rostami SY, Badkerhanian A, Parsons RF, Koeberlein B, Yu M, et al. In vivo BLyS/BAFF neutralization ameliorates islet-directed autoimmunity in nonobese diabetic mice. J Immunol. 2008;181(11):8133–44.
-
(2008)
J Immunol
, vol.181
, Issue.11
, pp. 8133-8144
-
-
Zekavat, G.1
Rostami, S.Y.2
Badkerhanian, A.3
Parsons, R.F.4
Koeberlein, B.5
Yu, M.6
-
7
-
-
0035889964
-
B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice
-
COI: 1:CAS:528:DC%2BD3MXotlamtrk%3D, PID: 11698422
-
Hulbert C, Riseili B, Rojas M, Thomas JW. B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J Immunol. 2001;167(10):5535–8.
-
(2001)
J Immunol
, vol.167
, Issue.10
, pp. 5535-5538
-
-
Hulbert, C.1
Riseili, B.2
Rojas, M.3
Thomas, J.W.4
-
8
-
-
70449480577
-
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function
-
COI: 1:CAS:528:DC%2BD1MXhsFSnsbnP, PID: 19940299, Seminal clinical study shows that anti-CD20 (Rituximab) therapy, which by broadly depleting B cells can delay disease progression in new onset human patients
-
Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R, et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med. 2009;361(22):2143–52. Seminal clinical study shows that anti-CD20 (Rituximab) therapy, which by broadly depleting B cells can delay disease progression in new onset human patients.
-
(2009)
N Engl J Med
, vol.361
, Issue.22
, pp. 2143-2152
-
-
Pescovitz, M.D.1
Greenbaum, C.J.2
Krause-Steinrauf, H.3
Becker, D.J.4
Gitelman, S.E.5
Goland, R.6
-
9
-
-
58149464696
-
A review of the current use of rituximab in autoimmune diseases
-
PID: 19000786
-
Gurcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Ahmed AR. A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol. 2009;9(1):10–25. doi:10.1016/j.intimp.2008.10.004.
-
(2009)
Int Immunopharmacol
, vol.9
, Issue.1
, pp. 10-25
-
-
Gurcan, H.M.1
Keskin, D.B.2
Stern, J.N.3
Nitzberg, M.A.4
Shekhani, H.5
Ahmed, A.R.6
-
10
-
-
0041689676
-
Predominant autoantibody production by early human B cell precursors
-
COI: 1:CAS:528:DC%2BD3sXmvFeltbo%3D, PID: 12920303
-
Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science. 2003;301(5638):1374–7. doi:10.1126/science.1086907.
-
(2003)
Science
, vol.301
, Issue.5638
, pp. 1374-1377
-
-
Wardemann, H.1
Yurasov, S.2
Schaefer, A.3
Young, J.W.4
Meffre, E.5
Nussenzweig, M.C.6
-
11
-
-
84876731066
-
Antigen and cytokine receptor signals guide the development of the naive mature B cell repertoire
-
COI: 1:CAS:528:DC%2BC3sXoslOltA%3D%3D, PID: 22941591
-
Rowland SL, Tuttle K, Torres RM, Pelanda R. Antigen and cytokine receptor signals guide the development of the naive mature B cell repertoire. Immunol Res. 2013;55(1–3):231–40. doi:10.1007/s12026-012-8366-7.
-
(2013)
Immunol Res
, vol.55
, Issue.1-3
, pp. 231-240
-
-
Rowland, S.L.1
Tuttle, K.2
Torres, R.M.3
Pelanda, R.4
-
12
-
-
33748992038
-
Receptor editing in lymphocyte development and central tolerance
-
COI: 1:CAS:528:DC%2BD28XhtVSgurnP, PID: 16998507
-
Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol. 2006;6(10):728–40. doi:10.1038/nri1939.
-
(2006)
Nat Rev Immunol
, vol.6
, Issue.10
, pp. 728-740
-
-
Nemazee, D.1
-
13
-
-
0034608364
-
Revising B cell receptors
-
COI: 1:CAS:528:DC%2BD3cXjvFyntL4%3D, PID: 10839798
-
Nemazee D, Weigert M. Revising B cell receptors. J Exp Med. 2000;191(11):1813–7.
-
(2000)
J Exp Med
, vol.191
, Issue.11
, pp. 1813-1817
-
-
Nemazee, D.1
Weigert, M.2
-
14
-
-
77955916272
-
Molecular underpinning of B-cell anergy
-
COI: 1:CAS:528:DC%2BC3cXhtFKrtbzF, PID: 20727040
-
Yarkoni Y, Getahun A, Cambier JC. Molecular underpinning of B-cell anergy. Immunol Rev. 2010;237(1):249–63. doi:10.1111/j.1600-065X.2010.00936.x.
-
(2010)
Immunol Rev
, vol.237
, Issue.1
, pp. 249-263
-
-
Yarkoni, Y.1
Getahun, A.2
Cambier, J.C.3
-
15
-
-
74649085316
-
B cell activation versus anergy; the antigen receptor as a molecular switch
-
COI: 1:CAS:528:DC%2BC3cXhtlegtrg%3D, PID: 19808046
-
Cambier JC, Getahun A. B cell activation versus anergy; the antigen receptor as a molecular switch. Immunol Lett. 2010;128(1):6–7. doi:10.1016/j.imlet.2009.09.006.
-
(2010)
Immunol Lett
, vol.128
, Issue.1
, pp. 6-7
-
-
Cambier, J.C.1
Getahun, A.2
-
16
-
-
34547193611
-
B-cell anergy: from transgenic models to naturally occurring anergic B cells?
-
COI: 1:CAS:528:DC%2BD2sXotFahtLo%3D, PID: 17641666
-
Cambier JC, Gauld SB, Merrell KT, Vilen BJ. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol. 2007;7(8):633–43.
-
(2007)
Nat Rev Immunol
, vol.7
, Issue.8
, pp. 633-643
-
-
Cambier, J.C.1
Gauld, S.B.2
Merrell, K.T.3
Vilen, B.J.4
-
17
-
-
27544458293
-
Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling
-
COI: 1:CAS:528:DC%2BD2MXhtFamsb7L, PID: 16200069
-
Gauld SB, Benschop RJ, Merrell KT, Cambier JC. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat Immunol. 2005;6(11):1160–7.
-
(2005)
Nat Immunol
, vol.6
, Issue.11
, pp. 1160-1167
-
-
Gauld, S.B.1
Benschop, R.J.2
Merrell, K.T.3
Cambier, J.C.4
-
18
-
-
46149085377
-
Understanding B-cell tolerance through the use of immunoglobulin transgenic models
-
COI: 1:CAS:528:DC%2BD1cXntVOlsbo%3D, PID: 17943232
-
Kumar KR, Mohan C. Understanding B-cell tolerance through the use of immunoglobulin transgenic models. Immunol Res. 2008;40(3):208–23. doi:10.1007/s12026-007-8008-7.
-
(2008)
Immunol Res
, vol.40
, Issue.3
, pp. 208-223
-
-
Kumar, K.R.1
Mohan, C.2
-
19
-
-
0031897046
-
Positive versus negative signaling by lymphocyte antigen receptors
-
COI: 1:CAS:528:DyaK1cXisl2ntb0%3D, PID: 9597145
-
Healy JI, Goodnow CC. Positive versus negative signaling by lymphocyte antigen receptors. Annu Rev Immunol. 1998;16:645–70. doi:10.1146/annurev.immunol.16.1.645.
-
(1998)
Annu Rev Immunol
, vol.16
, pp. 645-670
-
-
Healy, J.I.1
Goodnow, C.C.2
-
20
-
-
1842476272
-
B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice
-
COI: 1:CAS:528:DC%2BD2cXivVShu7w%3D, PID: 15067092
-
Silveira PA, Dombrowsky J, Johnson E, Chapman HD, Nemazee D, Serreze DV. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol. 2004;172(8):5086–94.
-
(2004)
J Immunol
, vol.172
, Issue.8
, pp. 5086-5094
-
-
Silveira, P.A.1
Dombrowsky, J.2
Johnson, E.3
Chapman, H.D.4
Nemazee, D.5
Serreze, D.V.6
-
21
-
-
78649603355
-
Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a beta-cell neo-self-antigen in type 1 diabetes prone NOD mice
-
COI: 1:CAS:528:DC%2BC3cXhsVOktbnP, PID: 21108464, Prior studies of NOD B cell tolerance using mice transgenic for both anti-hen egg lysozyme (HEL) BCR and HEL autoantigen expressed HEL systemically. Here autoantigen expression is driven by the insulin promoter and confined to the pancreas. Thus, it is a far more physiologically relevant model to understand the roots of T1D pathogenesis
-
Cox SL, Stolp J, Hallahan NL, Counotte J, Zhang W, Serreze DV, et al. Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a beta-cell neo-self-antigen in type 1 diabetes prone NOD mice. Eur J Immunol. 2010;40(12):3413–25. doi:10.1002/eji.201040817. Prior studies of NOD B cell tolerance using mice transgenic for both anti-hen egg lysozyme (HEL) BCR and HEL autoantigen expressed HEL systemically. Here autoantigen expression is driven by the insulin promoter and confined to the pancreas. Thus, it is a far more physiologically relevant model to understand the roots of T1D pathogenesis.
-
(2010)
Eur J Immunol
, vol.40
, Issue.12
, pp. 3413-3425
-
-
Cox, S.L.1
Stolp, J.2
Hallahan, N.L.3
Counotte, J.4
Zhang, W.5
Serreze, D.V.6
-
22
-
-
33744924210
-
Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse
-
COI: 1:CAS:528:DC%2BD28Xlt1CltLY%3D, PID: 16751358
-
Quinn 3rd WJ, Noorchashm N, Crowley JE, Reed AJ, Noorchashm H, Naji A, et al. Cutting edge: impaired transitional B cell production and selection in the nonobese diabetic mouse. J Immunol. 2006;176(12):7159–64.
-
(2006)
J Immunol
, vol.176
, Issue.12
, pp. 7159-7164
-
-
Quinn, W.J.1
Noorchashm, N.2
Crowley, J.E.3
Reed, A.J.4
Noorchashm, H.5
Naji, A.6
-
23
-
-
33845398322
-
Identification of anergic B cells within a wild-type repertoire
-
COI: 1:CAS:528:DC%2BD2sXisFeiug%3D%3D, PID: 17174121
-
Merrell KT, Benschop RJ, Gauld SB, Aviszus K, Decote-Ricardo D, Wysocki LJ, et al. Identification of anergic B cells within a wild-type repertoire. Immunity. 2006;25(6):953–62.
-
(2006)
Immunity
, vol.25
, Issue.6
, pp. 953-962
-
-
Merrell, K.T.1
Benschop, R.J.2
Gauld, S.B.3
Aviszus, K.4
Decote-Ricardo, D.5
Wysocki, L.J.6
-
24
-
-
17044400224
-
The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11
-
COI: 1:CAS:528:DC%2BD2MXivFKitbc%3D, PID: 15814708
-
Rolf J, Motta V, Duarte N, Lundholm M, Berntman E, Bergman ML, et al. The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J Immunol. 2005;174(8):4821–7.
-
(2005)
J Immunol
, vol.174
, Issue.8
, pp. 4821-4827
-
-
Rolf, J.1
Motta, V.2
Duarte, N.3
Lundholm, M.4
Berntman, E.5
Bergman, M.L.6
-
25
-
-
0033977135
-
Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice
-
COI: 1:CAS:528:DC%2BD3cXos1yrtQ%3D%3D, PID: 10607490
-
Wither JE, Roy V, Brennan LA. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice. Clin Immunol. 2000;94(1):51–63. doi:10.1006/clim.1999.4806.
-
(2000)
Clin Immunol
, vol.94
, Issue.1
, pp. 51-63
-
-
Wither, J.E.1
Roy, V.2
Brennan, L.A.3
-
26
-
-
0035013708
-
Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens
-
COI: 1:CAS:528:DC%2BD3MXktVantLc%3D, PID: 11371363
-
Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 2001;14(5):617–29.
-
(2001)
Immunity
, vol.14
, Issue.5
, pp. 617-629
-
-
Martin, F.1
Oliver, A.M.2
Kearney, J.F.3
-
27
-
-
1642536499
-
Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells
-
COI: 1:CAS:528:DC%2BD2cXnvVen, PID: 14707050
-
Attanavanich K, Kearney JF. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol. 2004;172(2):803–11.
-
(2004)
J Immunol
, vol.172
, Issue.2
, pp. 803-811
-
-
Attanavanich, K.1
Kearney, J.F.2
-
28
-
-
59649105484
-
RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes
-
COI: 1:CAS:528:DC%2BD1MXosFCn, PID: 19075293
-
Panigrahi AK, Goodman NG, Eisenberg RA, Rickels MR, Naji A, Luning Prak ET. RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes. J Exp Med. 2008;205(13):2985–94. doi:10.1084/jem.20082053.
-
(2008)
J Exp Med
, vol.205
, Issue.13
, pp. 2985-2994
-
-
Panigrahi, A.K.1
Goodman, N.G.2
Eisenberg, R.A.3
Rickels, M.R.4
Naji, A.5
Luning Prak, E.T.6
-
29
-
-
84855369247
-
Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant
-
COI: 1:CAS:528:DC%2BC3MXhs1GltrfI, PID: 22105996, Seminal work showing a human PTPN22 variant is capable of altering the integrity of B cell tolerance and ultimately increasing the risk of T1D
-
Habib T, Funk A, Rieck M, Brahmandam A, Dai X, Panigrahi AK, et al. Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J Immunol. 2012;188(1):487–96. doi:10.4049/jimmunol.1102176. Seminal work showing a human PTPN22 variant is capable of altering the integrity of B cell tolerance and ultimately increasing the risk of T1D.
-
(2012)
J Immunol
, vol.188
, Issue.1
, pp. 487-496
-
-
Habib, T.1
Funk, A.2
Rieck, M.3
Brahmandam, A.4
Dai, X.5
Panigrahi, A.K.6
-
30
-
-
72249122333
-
Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1
-
PID: 19741189
-
Orban T, Sosenko JM, Cuthbertson D, Krischer JP, Skyler JS, Jackson R, et al. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care. 2009;32(12):2269–74. doi:10.2337/dc09-0934.
-
(2009)
Diabetes Care
, vol.32
, Issue.12
, pp. 2269-2274
-
-
Orban, T.1
Sosenko, J.M.2
Cuthbertson, D.3
Krischer, J.P.4
Skyler, J.S.5
Jackson, R.6
-
31
-
-
36749011882
-
The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
-
COI: 1:CAS:528:DC%2BD2sXht1KgtLfM, PID: 17942684
-
Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A. 2007;104(43):17040–5. doi:10.1073/pnas.0705894104.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, Issue.43
, pp. 17040-17045
-
-
Wenzlau, J.M.1
Juhl, K.2
Yu, L.3
Moua, O.4
Sarkar, S.A.5
Gottlieb, P.6
-
32
-
-
84856689949
-
Development of autoantibodies in the TrialNet Natural History Study
-
PID: 21750277
-
Vehik K, Beam CA, Mahon JL, Schatz DA, Haller MJ, Sosenko JM, et al. Development of autoantibodies in the TrialNet Natural History Study. Diabetes Care. 2011;34(9):1897–901. doi:10.2337/dc11-0560.
-
(2011)
Diabetes Care
, vol.34
, Issue.9
, pp. 1897-1901
-
-
Vehik, K.1
Beam, C.A.2
Mahon, J.L.3
Schatz, D.A.4
Haller, M.J.5
Sosenko, J.M.6
-
33
-
-
0142061950
-
The prevalence of insulin autoantibodies at the onset of type 1 diabetes is higher in males than females during adolescence
-
COI: 1:CAS:528:DC%2BD3sXnvVCguro%3D, PID: 13680123
-
Williams AJ, Norcross AJ, Dix RJ, Gillespie KM, Gale EA, Bingley PJ. The prevalence of insulin autoantibodies at the onset of type 1 diabetes is higher in males than females during adolescence. Diabetologia. 2003;46(10):1354–6. doi:10.1007/s00125-003-1197-2.
-
(2003)
Diabetologia
, vol.46
, Issue.10
, pp. 1354-1356
-
-
Williams, A.J.1
Norcross, A.J.2
Dix, R.J.3
Gillespie, K.M.4
Gale, E.A.5
Bingley, P.J.6
-
34
-
-
0023722804
-
Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age
-
COI: 1:STN:280:DyaL1M7js1Ohtw%3D%3D, PID: 3066606
-
Vardi P, Ziegler AG, Mathews JH, Dib S, Keller RJ, Ricker AT, et al. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care. 1988;11(9):736–9.
-
(1988)
Diabetes Care
, vol.11
, Issue.9
, pp. 736-739
-
-
Vardi, P.1
Ziegler, A.G.2
Mathews, J.H.3
Dib, S.4
Keller, R.J.5
Ricker, A.T.6
-
35
-
-
0035511862
-
International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice
-
COI: 1:CAS:528:DC%2BD3MXotFGisr8%3D, PID: 11679421
-
Bonifacio E, Atkinson M, Eisenbarth G, Serreze D, Kay TW, Lee-Chan E, et al. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice. Diabetes. 2001;50(11):2451–8.
-
(2001)
Diabetes
, vol.50
, Issue.11
, pp. 2451-2458
-
-
Bonifacio, E.1
Atkinson, M.2
Eisenbarth, G.3
Serreze, D.4
Kay, T.W.5
Lee-Chan, E.6
-
36
-
-
0034652317
-
Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes
-
COI: 1:CAS:528:DC%2BD3cXhsFCrtro%3D, PID: 10677521
-
Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K, et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A. 2000;97(4):1701–6.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, Issue.4
, pp. 1701-1706
-
-
Yu, L.1
Robles, D.T.2
Abiru, N.3
Kaur, P.4
Rewers, M.5
Kelemen, K.6
-
37
-
-
4644225746
-
Investigation of the role of B-cells in type 1 diabetes in the NOD mouse
-
COI: 1:CAS:528:DC%2BD2cXotFymtrs%3D, PID: 15448087
-
Wong FS, Wen L, Tang M, Ramanathan M, Visintin I, Daugherty J, et al. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes. 2004;53(10):2581–7.
-
(2004)
Diabetes
, vol.53
, Issue.10
, pp. 2581-2587
-
-
Wong, F.S.1
Wen, L.2
Tang, M.3
Ramanathan, M.4
Visintin, I.5
Daugherty, J.6
-
38
-
-
84897505588
-
In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesis
-
COI: 1:CAS:528:DC%2BC2cXkslams74%3D, PID: 24610011, Prior to publication of this paper, insulin-specfic B cells were the only islet autoantigen specific B cells identified in the NOD mouse model. Though the importance of peripherin as a pancreatic antigen remains to be determined, the presence of the these B cells in the pancreas is an intriguing finding
-
Garabatos N, Alvarez R, Carrillo J, Carrascal J, Izquierdo C, Chapman HD, et al. In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesis. J Immunol. 2014;192(7):3080–90. doi:10.4049/jimmunol.1301053. Prior to publication of this paper, insulin-specfic B cells were the only islet autoantigen specific B cells identified in the NOD mouse model. Though the importance of peripherin as a pancreatic antigen remains to be determined, the presence of the these B cells in the pancreas is an intriguing finding.
-
(2014)
J Immunol
, vol.192
, Issue.7
, pp. 3080-3090
-
-
Garabatos, N.1
Alvarez, R.2
Carrillo, J.3
Carrascal, J.4
Izquierdo, C.5
Chapman, H.D.6
-
39
-
-
0033564970
-
I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice
-
COI: 1:CAS:528:DyaK1MXksVegur4%3D, PID: 10395666
-
Noorchashm H, Lieu YK, Noorchashm N, Rostami SY, Greeley SA, Schlachterman A, et al. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol. 1999;163(2):743–50.
-
(1999)
J Immunol
, vol.163
, Issue.2
, pp. 743-750
-
-
Noorchashm, H.1
Lieu, Y.K.2
Noorchashm, N.3
Rostami, S.Y.4
Greeley, S.A.5
Schlachterman, A.6
-
40
-
-
84868008849
-
B-cell cross-presentation of autologous antigen precipitates diabetes
-
COI: 1:CAS:528:DC%2BC38Xhsl2it7vJ, PID: 22829452, A clear demonstration of the importance of B cells in cross presenting autoantigen to self-reactive CD8+ T cells
-
Marino E, Tan B, Binge L, Mackay CR, Grey ST. B-cell cross-presentation of autologous antigen precipitates diabetes. Diabetes. 2012;61(11):2893–905. doi:10.2337/db12-0006. A clear demonstration of the importance of B cells in cross presenting autoantigen to self-reactive CD8+ T cells.
-
(2012)
Diabetes
, vol.61
, Issue.11
, pp. 2893-2905
-
-
Marino, E.1
Tan, B.2
Binge, L.3
Mackay, C.R.4
Grey, S.T.5
-
41
-
-
11844290756
-
Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis
-
COI: 1:CAS:528:DC%2BD2MXotFSr, PID: 15634886
-
Hussain S, Delovitch TL. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. J Immunol. 2005;174(2):680–7.
-
(2005)
J Immunol
, vol.174
, Issue.2
, pp. 680-687
-
-
Hussain, S.1
Delovitch, T.L.2
-
42
-
-
0036918641
-
The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors
-
COI: 1:CAS:528:DC%2BD3sXjt12j, PID: 12516557
-
Silveira PA, Johnson E, Chapman HD, Bui T, Tisch RM, Serreze DV. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur J Immunol. 2002;32(12):3657–66.
-
(2002)
Eur J Immunol
, vol.32
, Issue.12
, pp. 3657-3666
-
-
Silveira, P.A.1
Johnson, E.2
Chapman, H.D.3
Bui, T.4
Tisch, R.M.5
Serreze, D.V.6
-
43
-
-
84874885423
-
Tolerant anti-insulin B cells are effective APCs
-
COI: 1:CAS:528:DC%2BC3sXjsFGqtbc%3D, PID: 23396943, Though the study is largely an in vitro demonstration of antigen presentation, it does show that insulin-binding 125Tg B cells are more competent presenters of insulin peptides than their non insulin-binding counterparts. Suggesting they may be in vivo potent antigen presenting cells as well
-
Kendall PL, Case JB, Sullivan AM, Holderness JS, Wells KS, Liu E, et al. Tolerant anti-insulin B cells are effective APCs. J Immunol. 2013;190(6):2519–26. doi:10.4049/jimmunol.1202104. Though the study is largely an in vitro demonstration of antigen presentation, it does show that insulin-binding 125Tg B cells are more competent presenters of insulin peptides than their non insulin-binding counterparts. Suggesting they may be in vivo potent antigen presenting cells as well.
-
(2013)
J Immunol
, vol.190
, Issue.6
, pp. 2519-2526
-
-
Kendall, P.L.1
Case, J.B.2
Sullivan, A.M.3
Holderness, J.S.4
Wells, K.S.5
Liu, E.6
-
45
-
-
42449144715
-
HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families
-
COI: 1:CAS:528:DC%2BD1cXksVGrsr4%3D, PID: 18252895
-
Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes. 2008;57(4):1084–92. doi:10.2337/db07-1331.
-
(2008)
Diabetes
, vol.57
, Issue.4
, pp. 1084-1092
-
-
Erlich, H.1
Valdes, A.M.2
Noble, J.3
Carlson, J.A.4
Varney, M.5
Concannon, P.6
-
46
-
-
58149299735
-
Analysis of islet inflammation in human type 1 diabetes
-
COI: 1:STN:280:DC%2BD1M%2FlslKltw%3D%3D, PID: 19128359
-
Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol. 2009;155(2):173–81. doi:10.1111/j.1365-2249.2008.03860.x.
-
(2009)
Clin Exp Immunol
, vol.155
, Issue.2
, pp. 173-181
-
-
Willcox, A.1
Richardson, S.J.2
Bone, A.J.3
Foulis, A.K.4
Morgan, N.G.5
-
47
-
-
84930791607
-
Insulitis in human type 1 diabetes: a comparison between patients and animal models
-
In't VP. Insulitis in human type 1 diabetes: a comparison between patients and animal models. Semin Immunopathol. 2014. doi:10.1007/s00281-014-0438-4.
-
(2014)
Semin Immunopathol
-
-
In't, V.P.1
-
48
-
-
60849137241
-
High-resolution three-dimensional imaging of islet-infiltrate interactions based on optical projection tomography assessments of the intact adult mouse pancreas
-
PID: 19021448
-
Alanentalo T, Loren CE, Larefalk A, Sharpe J, Holmberg D, Ahlgren U. High-resolution three-dimensional imaging of islet-infiltrate interactions based on optical projection tomography assessments of the intact adult mouse pancreas. J Biomed Opt. 2008;13(5):054070. doi:10.1117/1.3000430.
-
(2008)
J Biomed Opt
, vol.13
, Issue.5
, pp. 054070
-
-
Alanentalo, T.1
Loren, C.E.2
Larefalk, A.3
Sharpe, J.4
Holmberg, D.5
Ahlgren, U.6
-
49
-
-
79960088916
-
Insulitis in human type 1 diabetes: the quest for an elusive lesion
-
In't VP. Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets. 2011;3(4):131–8.
-
(2011)
Islets
, vol.3
, Issue.4
, pp. 131-138
-
-
In't, V.P.1
-
50
-
-
0035879105
-
Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice
-
COI: 1:CAS:528:DC%2BD3MXotFWktbk%3D, PID: 11441119
-
Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol. 2001;167(2):1081–9.
-
(2001)
J Immunol
, vol.167
, Issue.2
, pp. 1081-1089
-
-
Tian, J.1
Zekzer, D.2
Hanssen, L.3
Lu, Y.4
Olcott, A.5
Kaufman, D.L.6
-
51
-
-
43049156086
-
+ phenotype controls T cell-dependent inflammatory responses
-
COI: 1:CAS:528:DC%2BD1cXmtlagt78%3D, PID: 18482568
-
+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008;28(5):639–50. doi:10.1016/j.immuni.2008.03.017.
-
(2008)
Immunity
, vol.28
, Issue.5
, pp. 639-650
-
-
Yanaba, K.1
Bouaziz, J.D.2
Haas, K.M.3
Poe, J.C.4
Fujimoto, M.5
Tedder, T.F.6
-
52
-
-
84898466276
-
Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD mice
-
PID: 24465383, Seminal demonstration of how tolerogenic dendritic cells may be exploited to expand a population of immunosuppressive B cells, widely referred to as B-regulatory cells (Bregs) and suppress T1D
-
Di Caro V, Phillips B, Engman C, Harnaha J, Trucco M, Giannoukakis N. Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD mice. PLoS One. 2014;9(1):e83575. doi:10.1371/journal.pone.0083575. Seminal demonstration of how tolerogenic dendritic cells may be exploited to expand a population of immunosuppressive B cells, widely referred to as B-regulatory cells (Bregs) and suppress T1D.
-
(2014)
PLoS One
, vol.9
, Issue.1
, pp. e83575
-
-
Di Caro, V.1
Phillips, B.2
Engman, C.3
Harnaha, J.4
Trucco, M.5
Giannoukakis, N.6
-
53
-
-
84878978312
-
Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells
-
COI: 1:CAS:528:DC%2BC3sXhtFOlsb7M, PID: 23716674
-
Montandon R, Korniotis S, Layseca-Espinosa E, Gras C, Megret J, Ezine S, et al. Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells. Proc Natl Acad Sci U S A. 2013;110(24):E2199–208. doi:10.1073/pnas.1222446110.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, Issue.24
, pp. E2199-E2208
-
-
Montandon, R.1
Korniotis, S.2
Layseca-Espinosa, E.3
Gras, C.4
Megret, J.5
Ezine, S.6
-
54
-
-
79957768363
-
B cell-directed therapies in type 1 diabetes
-
COI: 1:CAS:528:DC%2BC3MXntFSms78%3D, PID: 21531625
-
Marino E, Silveira PA, Stolp J, Grey ST. B cell-directed therapies in type 1 diabetes. Trends Immunol. 2011;32(6):287–94. doi:10.1016/j.it.2011.03.006.
-
(2011)
Trends Immunol
, vol.32
, Issue.6
, pp. 287-294
-
-
Marino, E.1
Silveira, P.A.2
Stolp, J.3
Grey, S.T.4
-
55
-
-
84864390309
-
Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes
-
COI: 1:CAS:528:DC%2BC38XhtFOgu77F, PID: 22698916, Model approach of how specific targeting of B cells that recognize islet antigens effects disease development
-
Henry RA, Kendall PL, Thomas JW. Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes. Diabetes. 2012;61(8):2037–44. doi:10.2337/db11-1746. Model approach of how specific targeting of B cells that recognize islet antigens effects disease development.
-
(2012)
Diabetes
, vol.61
, Issue.8
, pp. 2037-2044
-
-
Henry, R.A.1
Kendall, P.L.2
Thomas, J.W.3
|